Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 109,620,596 shares of Common Stock outstanding as of August 12, 2025, as reported in the Company's Form 8-K filed with the U.S. Securities and Exchange Commission on October 16, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 109,620,596 shares of Common Stock outstanding as of August 12, 2025, as reported in the Company's Form 8-K filed with the U.S. Securities and Exchange Commission on October 16, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 109,620,596 shares of Common Stock outstanding as of August 12, 2025, as reported in the Company's Form 8-K filed with the U.S. Securities and Exchange Commission on October 16, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 109,620,596 shares of Common Stock outstanding as of August 12, 2025, as reported in the Company's Form 8-K filed with the U.S. Securities and Exchange Commission on October 16, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 109,620,596 shares of Common Stock outstanding as of August 12, 2025, as reported in the Company's Form 8-K filed with the U.S. Securities and Exchange Commission on October 16, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  Note to Row 11: The denominator for this calculation is based on 109,620,596 shares of Common Stock outstanding as of August 12, 2025, as reported in the Company's Form 8-K filed with the U.S. Securities and Exchange Commission on October 16, 2025.


SCHEDULE 13G



 
CRCM LP
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM LP
Date:10/27/2025
 
CRCM LLC
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM LLC
Date:10/27/2025
 
CRCM INSTITUTIONAL MASTER FUND (BVI), LTD.
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM INSTITUTIONAL MASTER FUND (BVI), LTD.
Date:10/27/2025
 
CRCM B SPV, LP
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM B SPV, LP
Date:10/27/2025
 
CRCM Fintech Fund, LP
 
Signature:/s/ Chun R. Ding
Name/Title:CRCM Fintech Fund, LP
Date:10/27/2025
 
DING CHUN R
 
Signature:/s/ Chun R. Ding
Name/Title:DING CHUN R
Date:10/27/2025
Exhibit Information

Exhibit 1 -- Joint Acquisition Statement Pursuant to Section 240.13d-1(k)